Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Psychotherapy: early-phase trial registry

4 of 5 indexed Psychotherapy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Psychotherapy: 5 US clinical trials tracked, 4 recruiting.

Psychotherapy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Yvan Beaussant, MD, MSci, running 1 of these trials.

Enrollment posture brief

Registry condition psychotherapy

OPEN 4 | RECR 80% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Psychotherapy (this)80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Psychotherapy

Psychotherapy lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Psychotherapy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Psychotherapy is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Psychotherapy research.

    Yvan Beaussant, MD, MSci accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Psychotherapy trials plan to enrol fewer than 100 people.

    Median target enrolment is 72 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Psychotherapy research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on Psychotherapy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Engage Behavioral
1 trials
Supportive Conversation Other
1 trials
EMPOWER Behavioral
1 trials
Therapy Other
1 trials
Standard Consultation (SC) Other
1 trials
Step up to session audio review Other
1 trials
Step down to fidelity self-monitoring Other
1 trials
Work Sample Review (WR) Other
1 trials

US sites by state

Facility locations filed on Psychotherapy trials. A trial with sites in several states counts in each.

Texas 1 trials
Ohio 1 trials
New York 1 trials
Nevada 1 trials
Minnesota 1 trials
Michigan 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Psychotherapy page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychotherapy condition card totals 5 registered trials; most-linked intervention Engage; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.